Memo Therapeutics AG
Announced 28 Jul 2026$763.0M ยท Hospitals and Health Care ยท Switzerland
Memo Therapeutics AG, an Ipsen company, is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections.